These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 16643399)
1. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. Probst V; Allouis M; Sacher F; Pattier S; Babuty D; Mabo P; Mansourati J; Victor J; Nguyen JM; Schott JJ; Boisseau P; Escande D; Le Marec H J Cardiovasc Electrophysiol; 2006 Mar; 17(3):270-5. PubMed ID: 16643399 [TBL] [Abstract][Full Text] [Related]
2. Does an overlap syndrome really exist between Brugada syndrome and progressive cardiac conduction defect (Lenegre syndrome)? Shimizu W J Cardiovasc Electrophysiol; 2006 Mar; 17(3):276-8. PubMed ID: 16643400 [No Abstract] [Full Text] [Related]
3. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104 [TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. Probst V; Kyndt F; Potet F; Trochu JN; Mialet G; Demolombe S; Schott JJ; Baró I; Escande D; Le Marec H J Am Coll Cardiol; 2003 Feb; 41(4):643-52. PubMed ID: 12598077 [TBL] [Abstract][Full Text] [Related]
5. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228 [TBL] [Abstract][Full Text] [Related]
6. Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome. Santos LF; Rodrigues B; Moreira D; Correia E; Nunes L; Costa A; Elvas L; Pereira T; Machado JC; Castedo S; Henriques C; Matos A; Santos JO Europace; 2012 Jun; 14(6):882-8. PubMed ID: 22277643 [TBL] [Abstract][Full Text] [Related]
7. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Schulze-Bahr E; Eckardt L; Breithardt G; Seidl K; Wichter T; Wolpert C; Borggrefe M; Haverkamp W Hum Mutat; 2003 Jun; 21(6):651-2. PubMed ID: 14961552 [TBL] [Abstract][Full Text] [Related]
8. Mutational screening of SCN5A linked disorders in Polish patients and their family members. Moric-Janiszewska E; Herbert E; Cholewa K; Filipecki A; Trusz-Gluza M; Wilczok T J Appl Genet; 2004; 45(3):383-90. PubMed ID: 15306732 [TBL] [Abstract][Full Text] [Related]
9. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617]. Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365 [TBL] [Abstract][Full Text] [Related]
10. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. Smits JP; Koopmann TT; Wilders R; Veldkamp MW; Opthof T; Bhuiyan ZA; Mannens MM; Balser JR; Tan HL; Bezzina CR; Wilde AA J Mol Cell Cardiol; 2005 Jun; 38(6):969-81. PubMed ID: 15910881 [TBL] [Abstract][Full Text] [Related]
11. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic criteria for the Brugada syndrome: can they be improved?]. Santos LF; Pereira T; Rodrigues B; Correia E; Moreira D; Nunes L; Costa A; Elvas L; Machado JC; Castedo S; Henriques C; Matos A; Santos O Rev Port Cardiol; 2012 May; 31(5):355-62. PubMed ID: 22475738 [TBL] [Abstract][Full Text] [Related]
14. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A. Itoh H; Shimizu M; Mabuchi H; Imoto K J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879 [TBL] [Abstract][Full Text] [Related]
17. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts. Herbert E; Chahine M Can J Physiol Pharmacol; 2006; 84(8-9):795-802. PubMed ID: 17111025 [TBL] [Abstract][Full Text] [Related]
18. Linkage analyses and SCN5A mutations screening in five sudden unexplained death syndrome (Lai-tai) families. Sangwatanaroj S; Yanatasneejit P; Sunsaneewitayakul B; Sitthisook S J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S54-61. PubMed ID: 12188452 [TBL] [Abstract][Full Text] [Related]
19. A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state. Keller DI; Barrane FZ; Gouas L; Martin J; Pilote S; Suarez V; Osswald S; Brink M; Guicheney P; Schwick N; Chahine M Can J Cardiol; 2005 Sep; 21(11):925-31. PubMed ID: 16239976 [TBL] [Abstract][Full Text] [Related]
20. Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Royer A; van Veen TA; Le Bouter S; Marionneau C; Griol-Charhbili V; Léoni AL; Steenman M; van Rijen HV; Demolombe S; Goddard CA; Richer C; Escoubet B; Jarry-Guichard T; Colledge WH; Gros D; de Bakker JM; Grace AA; Escande D; Charpentier F Circulation; 2005 Apr; 111(14):1738-46. PubMed ID: 15809371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]